Healthcare -
Biotechnology - NASDAQ - US
$ 18.08
3.79 %
$ 550 M
Market Cap
-2.99
P/E
ANAB - STOCK-BASED COMPENSATION
Stock-based Compensation ANAB - AnaptysBio, Inc.
33.2 M
LAST VALUE
47.09%
2 YEAR CAGR
27.23%
5 YEAR CAGR
71.48%
10 YEAR CAGR